Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Incorporating genomics into breast and prostate cancer screening: assessing the implications.

Chowdhury S, Dent T, Pashayan N, Hall A, Lyratzopoulos G, Hallowell N, Hall P, Pharoah P, Burton H.

Genet Med. 2013 Jun;15(6):423-32. doi: 10.1038/gim.2012.167. Epub 2013 Feb 14. Review.

2.

Public health implications from COGS and potential for risk stratification and screening.

Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.

Nat Genet. 2013 Apr;45(4):349-51. doi: 10.1038/ng.2582.

PMID:
23535723
3.

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.

Koitsalu M, Sprangers MA, Eklund M, Czene K, Hall P, Grönberg H, Brandberg Y.

Acta Oncol. 2016;55(1):45-51. doi: 10.3109/0284186X.2015.1043024. Epub 2015 May 20.

PMID:
25990635
4.

Stratified cancer screening: the practicalities of implementation.

Dent T, Jbilou J, Rafi I, Segnan N, Törnberg S, Chowdhury S, Hall A, Lyratzopoulos G, Eeles R, Eccles D, Hallowell N, Pashayan N, Pharoah P, Burton H.

Public Health Genomics. 2013;16(3):94-9. doi: 10.1159/000345941. Epub 2013 Jan 26.

PMID:
23363703
5.

Incorporating genomic data into multivariate risk models for lung cancer.

Young RP, Hopkins RJ.

Genet Med. 2013 Aug;15(8):667-8. doi: 10.1038/gim.2013.89. No abstract available.

PMID:
23912891
6.

Public health genomics and personalized prevention: lessons from the COGS project.

Pashayan N, Hall A, Chowdhury S, Dent T, Pharoah PD, Burton H.

J Intern Med. 2013 Nov;274(5):451-6. doi: 10.1111/joim.12094.

7.

How can polygenic inheritance be used in population screening for common diseases?

Khoury MJ, Janssens AC, Ransohoff DF.

Genet Med. 2013 Jun;15(6):437-43. doi: 10.1038/gim.2012.182. Epub 2013 Feb 14. Review.

8.

Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues.

Hall AE, Chowdhury S, Hallowell N, Pashayan N, Dent T, Pharoah P, Burton H.

J Public Health (Oxf). 2014 Jun;36(2):285-91. doi: 10.1093/pubmed/fdt078. Epub 2013 Aug 28. Review.

9.

Essential elements of personalized medicine.

Burke W, Brown Trinidad S, Press NA.

Urol Oncol. 2014 Feb;32(2):193-7. doi: 10.1016/j.urolonc.2013.09.002. Epub 2013 Dec 8.

10.

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.

Meisel SF, Rahman B, Side L, Fraser L, Gessler S, Lanceley A, Wardle J; PROMISE-2016 study team.

BMC Womens Health. 2016 Jul 26;16:46. doi: 10.1186/s12905-016-0325-3.

11.

Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening.

So HC, Kwan JS, Cherny SS, Sham PC.

Am J Hum Genet. 2011 May 13;88(5):548-65. doi: 10.1016/j.ajhg.2011.04.001. Epub 2011 Apr 28.

12.

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.

Pashayan N, Duffy SW, Neal DE, Hamdy FC, Donovan JL, Martin RM, Harrington P, Benlloch S, Amin Al Olama A, Shah M, Kote-Jarai Z, Easton DF, Eeles R, Pharoah PD.

Genet Med. 2015 Oct;17(10):789-95. doi: 10.1038/gim.2014.192. Epub 2015 Jan 8.

13.

Prostate cancer screening using risk stratification based on a multi-state model of genetic variants.

Yen AM, Auvinen A, Schleutker J, Wu YY, Fann JC, Tammela T, Chen SL, Chiu SY, Chen HH.

Prostate. 2015 Jun;75(8):825-35. doi: 10.1002/pros.22964. Epub 2015 Feb 14.

PMID:
25683204
14.

Screening for Cervical, Prostate, and Breast Cancer: Interpreting the Evidence.

Carter SM, Williams J, Parker L, Pickles K, Jacklyn G, Rychetnik L, Barratt A.

Am J Prev Med. 2015 Aug;49(2):274-85. doi: 10.1016/j.amepre.2015.01.009. Epub 2015 Jun 16. Review.

PMID:
26091929
15.

Mammography screening. Benefits, harms, and informed choice.

Jørgensen KJ.

Dan Med J. 2013 Apr;60(4):B4614. Review.

PMID:
23651722
16.

Enhancing citizen engagement in cancer screening through deliberative democracy.

Rychetnik L, Carter SM, Abelson J, Thornton H, Barratt A, Entwistle VA, Mackenzie G, Salkeld G, Glasziou P.

J Natl Cancer Inst. 2013 Mar 20;105(6):380-6. doi: 10.1093/jnci/djs649. Epub 2013 Feb 1.

PMID:
23378639
17.

["Screening" in special situations. Assessing predictive genetic screening for hereditary breast and colorectal cancer].

Jonas S, Wild C, Schamberger C.

Z Arztl Fortbild Qualitatssich. 2003 Feb;97(1):67-71. German.

PMID:
12669692
18.

Ethical, legal, and social issues in the translation of genomics into health care.

Badzek L, Henaghan M, Turner M, Monsen R.

J Nurs Scholarsh. 2013 Mar;45(1):15-24. doi: 10.1111/jnu.12000. Epub 2013 Jan 31.

PMID:
23369261
19.

Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations.

d'Agincourt-Canning L, Baird P.

Crit Rev Oncol Hematol. 2006 May;58(2):114-23. Epub 2006 Apr 4. Review.

PMID:
16600617
20.

The problems with risk selection; scientific and psychosocial aspects.

Hartman AR.

Recent Results Cancer Res. 2005;166:125-44. Review.

PMID:
15648188

Supplemental Content

Support Center